RxDoctor Payments Data

Rick Nelson, MD

Otology & Neurotology · Indianapolis, INNPI 1720287139

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (47.3%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Medtronic at 32.9% of the total.

$22,948in general payments, 2019–2025

Across 57 payments — averaging $402.59 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$8K
  • Iotamotion, Inc.$6K
  • Eli Lilly$4K
  • Cochlear Americas$4K
  • Stryker$1K
  • Leica Microsystems Inc.$113
  • plus $130 from 2 others
$317,476in research payments, 2019–2025

Across 29 payments — averaging $10,947 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cochlear Americas$317K

What the payments were for

  • Consulting fees$10,85047%
  • Speaking & faculty fees$6,49928%
  • Travel & lodging$2,0729%
  • Food & beverage$3,52715%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Medtronic(2 entities)14$7,547
Iotamotion, Inc.7$5,961
Eli Lilly1$4,000
Cochlear Americas21$3,740
Stryker9$1,456
Leica Microsystems Inc.1$113
Acclarent, Inc3$92
Advanced Bionics, LLC1$38

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otology & neurotology providers in Indianato place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$94,815
Medicare patients
169
Services billed
319

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth17$1,378
Acetazolamide14$989
Dexamethasone Sodium Phosphate15$731
Triamterene-HydrochlorothiazidTriamterene/Hydrochlorothiazid28$399
Ofloxacin19$227
Nortriptyline Hcl18$220
Betamethasone Valerate11$188
Prednisone12$34

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →